Randy Seidl

Andy Seid joined Bioluminescence Ventures as a Partner in 2023.
Mr. Seid brings extensive experience spanning investment banking and operational expertise within the biopharmaceutical sector.
Prior to BLV, he served as director in the global healthcare group at Bank of America where he partnered with CEOs, CFOs and board members in identifying and executing financial and strategic outcomes through fundraising (IPOs, follow-ons, private placements) and M&A transactions.
He held similar roles at Leerink Partners and UBS and collectively has led over 50 completed transactions in the life sciences space.
As a biopharma operator, he has driven successful corporate, business development and strategic finance outcomes across small and large biopharmaceutical companies including at Genentech and Sangamo.
Andy holds a B.A.
with a double major in Molecular and Cell Biology and Economics from UC Berkeley.